A Retrospective Review on Dysregulated Autophagy in Polycystic Ovary Syndrome: From Pathogenesis to Therapeutic Strategies

Abstract

The main purpose of this article is to explore the relationship between autophagy and the pathological mechanism of PCOS, and to find potential therapeutic methods that can alleviate the pathological mechanism of PCOS by targeting autophagy. Relevant literatures were searched in the following databases, including: PubMed, MEDLINE, Web of Science, Scopus. The search terms were “autophagy”, “PCOS”, “polycystic ovary syndrome”, “ovulation”, “hyperandrogenemia”, “insulin resistance”, “inflammatory state”, “circadian rhythm” and “treatment”, which were combined according to the retrieval methods of different databases. Through analysis, we uncovered that abnormal levels of autophagy were closely related to abnormal ovulation, insulin resistance, hyperandrogenemia, and low-grade inflammation in patients with PCOS. Lifestyle intervention, melatonin, vitamin D, and probiotics, etc. were able to improve the pathological mechanism of PCOS via targeting autophagy. In conclusion, autophagy disorder is a key pathological mechanism in PCOS and is also a potential target for drug development and design.

Keywords

polycystic ovary syndrome -  adrenal - autophagy - pathogenesis - therapeutic strategies - retrospective review

Publication History

Received: 26 November 2023

Accepted after revision: 26 February 2024

Article published online:
02 April 2024

• References

• 1 Azziz R, Carmina E, Chen Z. et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016; 2: 16057
• 2 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
• 3 Azziz R, Carmina E, Dewailly D. et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488
• 4 Kim JJ, Hwang KR, Oh SH. et al. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values. Fertil Steril 2019; 112: 959-966
• 5 Dunaif A. Perspectives in polycystic ovary syndrome: from hair to eternity. J Clin Endocrinol Metab 2016; 101: 759-768
• 6 Sermondade N, Huberlant S, Bourhis-Lefebvre V. et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update 2019; 25: 439-451
• 7 D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 2019; 43: 582-592
• 8 Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 2002; 84: 203-214
• 9 Tong C, Wu Y, Zhang L. et al. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway. Front Endocrinol (Lausanne) 2022; 13: 1091147
• 10 Kumariya S, Ubba V, Jha RK. et al. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy 2021; 17: 2706-2733
• 11 Cheng D, Zheng B, Sheng Y. et al. The roles of autophagy in the genesis and development of polycystic ovary syndrome. Reprod Sci 2023; 30: 2920-2931
• 12 Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-477
• 13 Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol 2015; 16: 461-472
• 14 Duerrschmidt N, Zabirnyk O, Nowicki M. et al. Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death. Endocrinology 2006; 147: 3851-3860
• 15 Vilser C, Hueller H, Nowicki M. et al. The variable expression of lectin-like oxidized low-density lipoprotein receptor (LOX-1) and signs of autophagy and apoptosis in freshly harvested human granulosa cells depend on gonadotropin dose, age, and body weight. Fertil Steril 2010; 93: 2706-2715
• 16 Stefansdottir A, Johnston ZC, Powles-Glover N. et al. Etoposide damages female germ cells in the developing ovary. BMC Cancer 2016; 16: 482
• 17 Yoshii SR, Mizushima N. Monitoring and Measuring Autophagy. Int J Mol Sci 2017; 18: 1865
• 18 Kabeya Y, Mizushima N, Ueno T. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-5728
• 19 Choi J, Jo M, Lee E. et al. Induction of apoptotic cell death via accumulation of autophagosomes in rat granulosa cells. Fertil Steril 2011; 95: 1482-1486
• 20 Choi J, Jo M, Lee E. et al. AKT is involved in granulosa cell autophagy regulation via mTOR signaling during rat follicular development and atresia. Reproduction 2014; 147: 73-80
• 21 Zheng Y, Ma L, Liu N. et al. Autophagy and apoptosis of porcine ovarian granulosa cells during follicular development. Animals (Basel) 2019; 9: 1111
• 22 Lai Q, Xiang W, Li Q. et al. Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome. Front Med 2018; 12: 518-524
• 23 Chu YL, Xu YR, Yang WX. et al. The role of FSH and TGF-β superfamily in follicle atresia. Aging (Albany NY) 2018; 10: 305-321
• 24 Yi S, Zheng B, Zhu Y. et al. Melatonin ameliorates excessive PINK1/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS. Am J Physiol Endocrinol Metab 2020; 319: E91-E101
• 25 Li D, You Y, Bi FF. et al. Autophagy is activated in the ovarian tissue of polycystic ovary syndrome. Reproduction 2018; 155: 85-92
• 26 Bas D, Abramovich D, Hernandez F. et al. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Cell Biol Int 2011; 35: 423-429
• 27 Anderson E, Lee GY. The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue Cell 1997; 29: 171-189
• 28 Xu B, Dai W, Liu L. et al. Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K/AKT/mTOR pathway. Endocr J 2022; 69: 863-875
• 29 Chen X, Tang H, Liang Y. et al. Acupuncture regulates the autophagy of ovarian granulosa cells in polycystic ovarian syndrome ovulation disorder by inhibiting the PI3K/AKT/mTOR pathway through LncMEG3. Biomed Pharmacother 2021; 144: 112288
• 30 Tziomalos K, Katsikis I, Papadakis E. et al. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Hum Reprod 2013; 28: 785-793
• 31 Li X, Qi J, Zhu Q. et al. The role of androgen in autophagy of granulosa cells from PCOS. Gynecol Endocrinol 2019; 35: 669-672
• 32 Anderson E, Lee GY. The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue Cell 1997; 29: 171-189
• 33 Tran S, Fairlie WD, Lee EF. BECLIN1: Protein Structure, Function and Regulation. Cells 2021; 10: 1522
• 34 Li T, Dong G, Kang Y. et al. Increased homocysteine regulated by androgen activates autophagy by suppressing the mammalian target of rapamycin pathway in the granulosa cells of polycystic ovary syndrome mice. Bioengineered 2022; 13: 10875-10888
• 35 Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004; 59: 141-154
• 36 Benrick A, Pillon NJ, Nilsson E. et al. Electroacupuncture mimics exercise-induced changes in skeletal muscle gene expression in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2020; 105: 2027-2041
• 37 Pugeat M, Crave JC, Elmidani M. et al. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 1991; 40: 841-849
• 38 Puder JJ, Müller B, Keller U. Letter re: the biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 2005; 90: 4419-4420
• 39 Wang Y, Hu Y, Sun C. et al. Down-regulation of Risa improves insulin sensitivity by enhancing autophagy. FASEB J 2016; 30: 3133-3145
• 40 Sumarac-Dumanovic M, Apostolovic M, Janjetovic K. et al. Downregulation of autophagy gene expression in endometria from women with polycystic ovary syndrome. Mol Cell Endocrinol 2017; 440: 116-124
• 41 Song X, Shen Q, Fan L. et al. Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome. Oncotarget 2018; 9: 11905-11921
• 42 Peng Y, Guo L, Gu A. et al. Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats. Mol Med 2020; 26: 73
• 43 Abuelezz NZ, Shabana ME, Rashed L. et al. Nanocurcumin modulates miR-223-3p and NF-κB levels in the pancreas of rat model of polycystic ovary syndrome to attenuate autophagy flare, insulin resistance and improve β cell mass. J Exp Pharmacol 2021; 13: 873-888
• 44 Moore RY. Circadian rhythms: basic neurobiology and clinical applications. Annu Rev Med 1997; 48: 253-266
• 45 Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010; 72: 517-549
• 46 Fernandez F. Circadian responses to fragmented light: research synopsis in humans. Yale J Biol Med 2019; 92: 337-348
• 47 Wright KJ, McHill AW, Birks BR. et al. Entrainment of the human circadian clock to the natural light-dark cycle. Curr Biol 2013; 23: 1554-1558
• 48 Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol 2014; 24: 90-99
• 49 Curtis AM, Bellet MM, Sassone-Corsi P. et al. Circadian clock proteins and immunity. Immunity 2014; 40: 178-186
• 50 Nakao N, Yasuo S, Nishimura A. et al. Circadian clock gene regulation of steroidogenic acute regulatory protein gene expression in preovulatory ovarian follicles. Endocrinology 2007; 148: 3031-3038
• 51 Gamble KL, Resuehr D, Johnson CH. Shift work and circadian dysregulation of reproduction. Front Endocrinol (Lausanne) 2013; 4: 92
• 52 Kang X, Jia L, Shen X. Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model. Biomed Res Int 2015; 943694
• 53 Paixão L, Ramos RB, Lavarda A. et al. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol 2017; 15: 12
• 54 Cruciani F, Trombetta B, Labuda D. et al. Genetic diversity patterns at the human clock gene period 2 are suggestive of population-specific positive selection. Eur J Hum Genet 2008; 16: 1526-1534
• 55 Sakamoto T, Uryu O, Tomioka K. The clock gene period plays an essential role in photoperiodic control of nymphal development in the cricket Modicogryllus siamensis. J Biol Rhythms 2009; 24: 379-390
• 56 Chen M, Xu Y, Miao B. et al. Expression pattern of circadian genes and steroidogenesis-related genes after testosterone stimulation in the human ovary. J Ovarian Res 2016; 9: 56
• 57 Zhang J, Liu J, Zhu K. et al. Effects of BMAL1-SIRT1-positive cycle on estrogen synthesis in human ovarian granulosa cells: an implicative role of BMAL1 in PCOS. Endocrine 2016; 53: 574-584
• 58 Blasco V, Pinto FM, Fernández-Atucha A. et al. Altered expression of the kisspeptin/KISS1R and neurokinin B/NK3R systems in mural granulosa and cumulus cells of patients with polycystic ovarian syndrome. J Assist Reprod Genet 2019; 36: 113-120
• 59 Prata LM, Baracat EC, Simões MJ. Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res 2004; 37: 987-995
• 60 Lim YC, Hoe V, Darus A. et al. Association between night-shift work, sleep quality and metabolic syndrome. Occup Environ Med 2018; 75: 716-723
• 61 Sharma A, Laurenti MC, Dalla MC. et al. Glucose metabolism during rotational shift-work in healthcare workers. Diabetologia 2017; 60: 1483-1490
• 62 Simon SL, McWhirter L, Diniz BC. et al. Morning circadian misalignment is associated with insulin resistance in girls with obesity and polycystic ovarian syndrome. J Clin Endocrinol Metab 2019; 104: 3525-3534
• 63 Chu W, Zhai J, Xu J. et al. Continuous light-induced PCOS-like changes in reproduction, metabolism, and gut microbiota in Sprague-Dawley rats. Front Microbiol 2019; 10: 3145
• 64 Olsvik HL, Lamark T, Takagi K. et al. FYCO1 contains a C-terminally extended, LC3A/B-preferring LC3-interacting region (LIR) motif required for efficient maturation of autophagosomes during basal autophagy. J Biol Chem 2015; 290: 29361-29374
• 65 Toledo M, Batista-Gonzalez A, Merheb E. et al. Autophagy regulates the liver clock and glucose metabolism by degrading CRY1. Cell Metab 2018; 28: 268-281
• 66 Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95: 1048-1058
• 67 Liu M, Gao J, Zhang Y. et al. Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation. Clin Endocrinol (Oxf) 2015; 83: 913-922
• 68 Zhang P, Zhang H, Lin J. et al. Insulin impedes osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence via the TGF-β1 pathway. Aging (Albany NY) 2020; 12: 2084-2100
• 69 Messer JS. The cellular autophagy/apoptosis checkpoint during inflammation. Cell Mol Life Sci 2017; 74: 1281-1296
• 70 Gu BX, Wang X, Yin BL. et al. Abnormal expression of TLRs may play a role in lower embryo quality of women with polycystic ovary syndrome. Syst Biol Reprod Med 2016; 62: 353-358
• 71 Xu Y, Jagannath C, Liu XD. et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27: 135-144
• 72 Lee HK, Lund JM, Ramanathan B. et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315: 1398-1401
• 73 Schube U, Nowicki M, Jogschies P. et al. Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration. J Clin Endocrinol Metab 2014; 99: 229-239
• 74 Lee JW, Nam H, Kim LE. et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy 2019; 15: 753-770
• 75 Liu P, Huang G, Wei T. et al. Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation. Biochim Biophys Acta Mol Basis Dis 2018; 1864: 764-777
• 76 Venkatesan T, Choi YW, Mun SP. et al. Pinus radiata bark extract induces caspase-independent apoptosis-like cell death in MCF-7 human breast cancer cells. Cell Biol Toxicol 2016; 32: 451-464
• 77 Park HJ, Lee SJ, Kim SH. et al. IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Mol Immunol 2011; 48: 720-727
• 78 Tsuboi K, Nishitani M, Takakura A. et al. Autophagy protects against colitis by the maintenance of normal gut microflora and secretion of mucus. J Biol Chem 2015; 290: 20511-20526
• 79 Nighot PK, Hu CA, Ma TY. Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation. J Biol Chem 2015; 290: 7234-7246
• 80 Goodman NF, Cobin RH, Futterweit W. et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-Part 1. Endocr Pract 2015; 21: 1291-1300
• 81 Schmidt TH, Khanijow K, Cedars MI. et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol 2016; 152: 391-398
• 82 Rocha AL, Oliveira FR, Azevedo RC. et al. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res. 2019; 8: F1000 Faculty Rev 565
• 83 Teede HJ, Misso ML, Costello MF. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110: 364-379
• 84 Liu M, Zhu H, Zhu Y. et al. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol 2021; 270: 113821
• 85 Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev 2017; 39: 46-58
• 86 Chaix A, Lin T, Le HD. et al. Time-restricted feeding prevents obesity and metabolic Syndrome in mice lacking a circadian clock. Cell Metab 2019; 29: 303-319
• 87 Cote I, Toklu HZ, Green SM. et al. Limiting feeding to the active phase reduces blood pressure without the necessity of caloric reduction or fat mass loss. Am J Physiol Regul Integr Comp Physiol 2018; 315: R751-R758
• 88 Mani K, Javaheri A, Diwan A. Lysosomes mediate benefits of intermittent fasting in cardiometabolic disease: the janitor is the undercover boss. Compr Physiol 2018; 8: 1639-1667
• 89 Jamshed H, Beyl RA, Della MD. et al. Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans. Nutrients 2019; 11: 1234
• 90 Martinez-Lopez N, Tarabra E, Toledo M. et al. System-wide Benefits of Intermeal Fasting by Autophagy. Cell Metab 2017; 26: 856-871
• 91 Moradkhani F, Moloudizargari M, Fallah M. et al. Immunoregulatory role of melatonin in cancer. J Cell Physiol 2020; 235: 745-757
• 92 Moloudizargari M, Moradkhani F, Asghari N. et al. NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants. Life Sci 2019; 231: 116585
• 93 Reiter RJ, Tan DX, Tamura H. et al. Clinical relevance of melatonin in ovarian and placental physiology: a review. Gynecol Endocrinol 2014; 30: 83-89
• 94 Asghari MH, Abdollahi M, de Oliveira MR. et al. A review of the protective role of melatonin during phosphine-induced cardiotoxicity: focus on mitochondrial dysfunction, oxidative stress and apoptosis. J Pharm Pharmacol 2017; 69: 236-243
• 95 Pai SA, Majumdar AS. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. J Pharm Pharmacol 2014; 66: 1710-1721
• 96 Chang CF, Huang HJ, Lee HC. et al. Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α-synuclein aggregation. J Pineal Res 2012; 52: 312-321
• 97 Zhou H, Chen J, Lu X. et al. Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells. J Pineal Res 2012; 52: 120-127
• 98 Xie F, Zhang J, Zhai M. et al. Melatonin ameliorates ovarian dysfunction by regulating autophagy in PCOS via the PI3K-Akt pathway. Reproduction 2021; 162: 73-82
• 99 Yi S, Zheng B, Zhu Y. et al. Melatonin ameliorates excessive PINK1/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS. Am J Physiol Endocrinol Metab 2020; 319: E91-E101
• 100 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
• 101 Pilz S, März W, Wellnitz B. et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927-3935
• 102 Mishra S, Das AK, Das S. Hypovitaminosis D and associated cardiometabolic risk in women with PCOS. J Clin Diagn Res 2016; 10: C1-C4
• 103 Wehr E, Pieber TR, Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 2011; 34: 757-763
• 104 Belenchia AM, Tosh AK, Hillman LS. et al. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013; 97: 774-781
• 105 Trummer C, Pilz S, Schwetz V. et al. Vitamin D, PCOS and androgens in men: a systematic review. Endocr Connect 2018; 7: R95-R113
• 106 Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H. et al. The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Horm Metab Res 2017; 49: 174-179
• 107 Mushegian AA. Autophagy and vitamin D. Sci Signal 2017; 10: eaan2526
• 108 Tavera-Mendoza LE, Westerling T, Libby E. et al. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl Acad Sci U S A 2017; 114: E2186-E2194
• 109 La Rovere RM, Roest G, Bultynck G. et al. Intracellular Ca(2+) signaling and Ca(2+) microdomains in the control of cell survival, apoptosis and autophagy. Cell Calcium 2016; 60: 74-87
• 110 Berridge MJ. Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis. J Physiol 2017; 595: 6825-6836
• 111 Lajtai K, Nagy CT, Tarszabó R. et al. Effects of vitamin D deficiency on proliferation and autophagy of ovarian and liver tissues in a rat model of polycystic ovary syndrome. Biomolecules 2019; 9: 471
• 112 Hill C, Guarner F, Reid G. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-514
• 113 Ahmadi S, Jamilian M, Karamali M. et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil (Camb) 2017; 20: 254-261
• 114 Della CL, Foreste V, Barra F. et al. Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opin Investig Drugs 2020; 29: 819-830
• 115 Zhang F, Ma T, Cui P. et al. Diversity of the gut microbiota in dihydrotestosterone-induced PCOS rats and the pharmacologic effects of diane-35, probiotics, and berberine. Front Microbiol 2019; 10: 175
• 116 Ahmadi S, Jamilian M, Karamali M. et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil (Camb) 2017; 20: 254-261
• 117 Ostadmohammadi V, Jamilian M, Bahmani F. et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res 2019; 12: 5
• 118 Tabrizi R, Ostadmohammadi V, Akbari M. et al. The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob. Proteins 2019; 14: 1-14
• 119 Gioacchini G, Dalla VL, Benato F. et al. Interplay between autophagy and apoptosis in the development of Danio rerio follicles and the effects of a probiotic. Reprod Fertil Dev 2013; 25: 1115-1125
• 120 Zaylaa M, Alard J, Kassaa IA. et al. Autophagy: a novel mechanism involved in the anti-inflammatory abilities of probiotics. Cell Physiol Biochem 2019; 53: 774-793
• 121 Lu R, Shang M, Zhang YG. et al. Lactic acid bacteria isolated from Korean kimchi activate the vitamin D receptor-autophagy signaling pathways. Inflamm Bowel Dis 2020; 26: 1199-1211
• 122 Shang M, Sun J. Vitamin D/VDR, probiotics, and gastrointestinal diseases. Curr Med Chem 2017; 24: 876-887